Johnson & Johnson to Acquire Heart Failure Treatment Developer V-Wave
V-Wave’s Ventura Interatrial Shunt, designed for patients with heart failure and reduced ejection fraction, will join Johnson & Johnson MedTech’s portfolio under the new agreement.